Endocrine therapy for advanced breast cancer: A review
- 1 February 1992
- journal article
- review article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 21 (1), 15-26
- https://doi.org/10.1007/bf01811960
Abstract
No abstract availableKeywords
This publication has 74 references indexed in Scilit:
- Cell kinetics as a prognostic indicator in node-negative breast cancerEuropean Journal of Cancer and Clinical Oncology, 1989
- On the role of additive hormone monotherapy with tamoxifen, medroxyprogesterone acetate and aminoglutethimide, in advanced breast cancerKlinische Wochenschrift, 1987
- The Use of Ketoconazole as an Inhibitor of Steroid ProductionNew England Journal of Medicine, 1987
- Aminoglutethimide in the treatment of premenopausal patients with metastatic breast cancerEuropean Journal of Cancer and Clinical Oncology, 1986
- A Randomized Trial of Chemotherapy and Hormonal Therapy in Advanced Breast CancerNew England Journal of Medicine, 1985
- A Randomized Trial Comparing Surgical Adrenalectomy with Aminoglutethimide plus Hydrocortisone in Women with Advanced Breast CancerNew England Journal of Medicine, 1981
- Oestrogen receptors, sites of metastatic disease and survival in recurrent breast cancerEuropean Journal of Cancer (1965), 1981
- A comparative trial of transsphenoidal hypophysectomy and estrogen suppression with aminoglutethimide in advanced breast cancerCancer, 1979
- Prospective, randomized clinical trial of two different high dosages of medroxyprogesterone acetate (MAP) in the treatment of metastatic breast cancerEuropean Journal of Cancer (1965), 1979
- ON THE TREATMENT OF INOPERABLE CASES OF CARCINOMA OF THE MAMMA: SUGGESTIONS FOR A NEW METHOD OF TREATMENT, WITH ILLUSTRATIVE CASES.1The Lancet, 1896